SI1861404T1 - Polimorfna oblika 6- 4-klorofenil)-2 2-dimetil-7-fenil-2 3-dihidro- 1H-pirolizin-5-ilocetne kisline - Google Patents

Polimorfna oblika 6- 4-klorofenil)-2 2-dimetil-7-fenil-2 3-dihidro- 1H-pirolizin-5-ilocetne kisline

Info

Publication number
SI1861404T1
SI1861404T1 SI200631089T SI200631089T SI1861404T1 SI 1861404 T1 SI1861404 T1 SI 1861404T1 SI 200631089 T SI200631089 T SI 200631089T SI 200631089 T SI200631089 T SI 200631089T SI 1861404 T1 SI1861404 T1 SI 1861404T1
Authority
SI
Slovenia
Prior art keywords
pyrrolizin
chlorophenyl
dihydro
dimethyl
phenyl
Prior art date
Application number
SI200631089T
Other languages
English (en)
Inventor
Wolfgang Albrecht
Thomas Kammermeier
Hans-Gunter Striegel
Philipp Merckle
Stefan Laufer
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Publication of SI1861404T1 publication Critical patent/SI1861404T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI200631089T 2005-03-21 2006-03-20 Polimorfna oblika 6- 4-klorofenil)-2 2-dimetil-7-fenil-2 3-dihidro- 1H-pirolizin-5-ilocetne kisline SI1861404T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005012971A DE102005012971A1 (de) 2005-03-21 2005-03-21 Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
PCT/EP2006/002539 WO2006100019A1 (en) 2005-03-21 2006-03-20 Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid
EP06723557A EP1861404B1 (en) 2005-03-21 2006-03-20 Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid

Publications (1)

Publication Number Publication Date
SI1861404T1 true SI1861404T1 (sl) 2011-11-30

Family

ID=36568591

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631089T SI1861404T1 (sl) 2005-03-21 2006-03-20 Polimorfna oblika 6- 4-klorofenil)-2 2-dimetil-7-fenil-2 3-dihidro- 1H-pirolizin-5-ilocetne kisline

Country Status (15)

Country Link
US (1) US8034837B2 (sl)
EP (1) EP1861404B1 (sl)
JP (1) JP5009280B2 (sl)
CN (1) CN101160311B (sl)
AT (1) ATE509932T1 (sl)
AU (1) AU2006226625B2 (sl)
CA (1) CA2602224A1 (sl)
DE (1) DE102005012971A1 (sl)
ES (1) ES2367274T3 (sl)
MX (1) MX2007011455A (sl)
PL (1) PL1861404T3 (sl)
PT (1) PT1861404E (sl)
RU (1) RU2007138924A (sl)
SI (1) SI1861404T1 (sl)
WO (1) WO2006100019A1 (sl)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3915450A1 (de) 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
US5260451A (en) * 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
DE4419247A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
DE4419315A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419246A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
ATE210461T1 (de) * 1996-02-13 2001-12-15 Searle & Co Zusammensetzungen mit immunosuppressiven wirkungen, welche 5-lipoxygenase-inhibitoren und cyclooxygenase-2-inhibitoren enthalten
EA004938B1 (ru) * 2000-01-28 2004-10-28 Меркле Гмбх Способ получения 6-(4-хлорфенил)-2,2-диметил-7-фенил-2,3-дигидро-1h-пирролизин-5-илуксусной кислоты
DE10141285A1 (de) * 2001-08-23 2003-03-27 Merckle Gmbh Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
ES2275218T3 (es) * 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.

Also Published As

Publication number Publication date
AU2006226625A1 (en) 2006-09-28
JP2008535809A (ja) 2008-09-04
CN101160311A (zh) 2008-04-09
CA2602224A1 (en) 2006-09-28
MX2007011455A (es) 2007-12-06
US20090209610A1 (en) 2009-08-20
RU2007138924A (ru) 2009-04-27
JP5009280B2 (ja) 2012-08-22
ES2367274T3 (es) 2011-11-02
PT1861404E (pt) 2011-09-01
EP1861404A1 (en) 2007-12-05
AU2006226625B2 (en) 2011-04-21
EP1861404B1 (en) 2011-05-18
CN101160311B (zh) 2010-11-24
PL1861404T3 (pl) 2011-12-30
US8034837B2 (en) 2011-10-11
ATE509932T1 (de) 2011-06-15
WO2006100019A1 (en) 2006-09-28
DE102005012971A1 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
TN2011000245A1 (en) Organic compounds
CR8249A (es) Forma cristalina gamma del clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que lo contienen
MX2010003155A (es) Derivados de ciclopropil aril amida y uso de los mismos.
CA2495967A1 (fr) Nouveau procede de synthese et nouvelle forme cristalline de l'agomelatine ainsi que les compositions pharmaceutiques qui la contiennent
ECSP066376A (es) FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
ECSP066375A (es) Forma cristalina gamma de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen
NZ596107A (en) Antiviral compounds and methods
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
EP2078721A3 (en) Thieno-pyrimidime compounds having fungicidal activity
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
PT2421879E (pt) Novos 7-deazapurina nucleósidos para utilizações terapêuticas
RS55499B1 (sr) Novi kristalni oblik iii agomelatina, postupak njegove proizvodnje i farmaceutske kompozicije koje ga sadrže
JO2770B1 (en) Organic compounds
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
WO2009134531A3 (en) Total synthesis of salinosporamide a and analogs thereof
WO2007117591A3 (en) Total synthesis of salinosporamide a and analogs thereof
WO2008140641A3 (en) Pure paliperidone and processes for preparing thereof
WO2010150279A3 (en) Process for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor
CA2585802A1 (en) Industrial process for the preparation of 17-hydroxy-6.beta.,7.beta.;15.beta.,16.beta.-bismethylene-3-oxo-17.alpha.pregn-4-ene-21-carboxylic acid.gamma.-lactone and key-intermediates for this process
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
WO2009140101A3 (en) Imidazopyridine compounds useful as mmp-13 inhibitors
WO2010077730A3 (en) Indanone inhibitors of acetylcholinesterase
WO2006031929A3 (en) Thiazolopyridine kinase inhibitors
WO2010056585A3 (en) Heteroaryl diamide compounds useful as mmp-13 inhibitors
WO2006076350A3 (en) Processes for the preparation of aminoethoxybenzyl alcohols